CCR5 and HIV infectious disease: In acquired immunodeficiencies, such as Human Immunodeficiency Virus (HIV) infection, the ZFN-mediated disruption of the CCR5 locus—a principal receptor for HIV entrance into host cells—in CD4+ T-cells or in CD34+ cells significantly reduced the viral replication in non-human primates [19].